Sponsors of clinical trials continue to face a difficult and time-consuming regulatory compliance requirement.

Volatility and shifting trends in the industry have made the present pharmaceuticals distribution network challenging to navigate. However, with difficulty comes opportunity.

In these difficult times, the pharmaceutical industry has found itself at the forefront of unparalleled problems.

During this time, the pharma business has faced immense and unexpected problems, which have had an impact on all of our lives.

In the last few years, the global pharmaceutical export business has experienced remarkable growth.